A note on cookies

We use cookies to improve your experience of our website. If you want to find out more see our Privacy Policy

Welcome to the Organ-on-a-Chip Technologies Network

Organ-on-a-Chip deviceAn Organ-Chip (Emulate, Inc.)

This network is a joint MRC, EPSRC and BBSRC funded Technology Touching Life initiative, designed to capture, inspire and grow UK research activity in the Organ-on-a-Chip research field.

An organ-on-a-chip is an engineered system in which the architecture, functions and surrounding physiochemical environment of a living human organ are recreated, allowing drugs or therapies to be tested on an in vitro system which recapitulates the in vivo one. The development of organ-on-a-chip in vitro models has grown from a nascent idea in 2000 to one of the most promising, fastest growing research areas in the world, predicted to achieve a compound growth rate of 38-57% over the next 5 years to become a multi-billion pound industry.

Our network aims are to:

  1. Develop a vibrant multidisciplinary research community, bringing focus to the varied Organ-on-a-Chip and In Vitro model research activity in the UK;
  2. Facilitate inter-disciplinary and inter-sectoral research collaborations, to develop the next generation of organ-on-a-chip research solutions;
  3. To train, support and inspire the next generation of outstanding leaders in organ-on-a-chip research.

Register to join the network »

Latest Tweets

  • Can data generated in non-animal models support decision making in chemical safety assessment??? Yes..but how do you overcome reluctance to use this information in a regulatory context? That's the challenge for delegates at today's @NC3Rs @Unilever workshop
    09:17 12-12-2018
  • Some great OOAC opportunities!
    We are pleased to announce 17 new NC3Rs-funded PhD studentships for 2019, including three joint awards with @TheBHF – the most we have ever funded in one year. Find out more about the research we will be supporting and how to apply for a studentship:
    10:01 10-12-2018

View More Tweets »

Back to Top